Evidence map›Paper›PMID 20214792›Full record

ArticleJournal of translational medicine2010

Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction.

Claus S Sondergaard, David A Hess, Dustin J Maxwell, Carla Weinheimer, Ivana Rosová, Michael H Creer, David Piwnica-Worms, Attila Kovacs, Lene Pedersen, Jan A Nolta

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Claus S SondergaardDepartment of Molecular Biology, Department of Hematology and Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
David A Hess
Dustin J Maxwell
Carla Weinheimer
Ivana Rosová
Michael H Creer
David Piwnica-Worms
Attila Kovacs
Lene Pedersen
Jan A Nolta
Washington University in St. Louis · USAarhus University · DKMallinckrodt (United States) · USCalifornia Institute for Regenerative Medicine · USCardinal Glennon Children’s Medical Center · USWestern University · CA

Funding

Immunodeficient Mouse Model of Stem Cell PlasticityR01DK061848 · NIDDK · WASHINGTON UNIVERSITY · PI NOLTA, JAN A. · 2001 to 2009
$2.7M
Functional dissection of human A-MSC vs BM-MSC phenotypeR01HL073256 · NHLBI · WASHINGTON UNIVERSITY · PI NOLTA, JAN A. · 2003 to 2010
$2.3M
EX VIVO STEM CELL MANIPULATION AND HUMAN HEMATOPOIESISR01DK053041 · NIDDK · WASHINGTON UNIVERSITY · PI NOLTA, JAN A. · 1998 to 2006
$1.6M
Shared LSRII Cytometer Equipment Application - UC Davis Stem Cell ProgramS10RR026825 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2010 to 2010
$500k
NCRR NIH HHS S10 RR026825NHLBI NIH HHS R01 HL073256NHLBI NIH HHS R01HL073256NIDDK NIH HHS 2R01DK53041NIDDK NIH HHS 2R01DK61848NIDDK NIH HHS R01 DK061848
6 · The paper itself

Abstract

unlabelledHuman stem cells from adult sources have been shown to contribute to the regeneration of muscle, liver, heart, and vasculature. The mechanisms by which this is accomplished are, however, still not well understood. We tested the engraftment and regenerative potential of human umbilical cord blood-derived ALDH(hi)Lin(-), and ALDH(lo)Lin(-) cells following transplantation to NOD/SCID or NOD/SCID beta2m null mice with experimentally induced acute myocardial infarction. We used combined nanoparticle labeling and whole organ fluorescent imaging to detect human cells in multiple organs 48 hours post transplantation. Engraftment and regenerative effects of cell treatment were assessed four weeks post transplantation. We found that ALDH(hi)Lin(-) stem cells specifically located to the site of injury 48 hours post transplantation and engrafted the infarcted heart at higher frequencies than ALDH(lo)Lin(-) committed progenitor cells four weeks post transplantation. We found no donor derived cardiomyocytes and few endothelial cells of donor origin. Cell treatment was not associated with any detectable functional improvement at the four week endpoint. There was, however, a significant increase in vascular density in the central infarct zone of ALDH(hi)Lin(-) cell-treated mice, as compared to PBS and ALDH(lo)Lin(-) cell-treated mice.

conclusionsOur data indicate that adult human stem cells do not become a significant part of the regenerating tissue, but rapidly home to and persist only temporarily at the site of hypoxic injury to exert trophic effects on tissue repair thereby enhancing vascular recovery.

Indexed as

Fetal BloodMyocardial InfarctionAdult Stem CellsAldehyde DehydrogenaseAnimalsCell LineageCell SeparationHumansMiceMice, Inbred NODMice, SCIDMyocardiumNeovascularization, PhysiologicRegenerationStem Cell TransplantationAldehyde Dehydrogenase

Identifiers

PMID20214792
PMCPMC2846892
OpenAlexW2167370260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.